Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Targeting glioblastoma with laser thermal treatment and innate immune reprogramming.
EF 2023-24
Résumé
Combining laser heat with a new drug therapy for better patient outcomes in the fight against brain cancer. Laser Interstitial Thermal Therapy (LITT) is a type of treatment that uses a laser to heat up and destroy cancer cells. The laser device is thin, flexible, and needs only a small hole in the skull for access to the tumor. This minimizes the amount of damage caused by the procedure, while also allowing treatments in areas of the brain that are hard for a surgeon to safely access. With minimal disruption to the surrounding healthy brain tissue and a quick post-operative recovery, LITT is an attractive treatment option, especially for very sick or otherwise high-risk patients. Glioblastoma multiforme (GBM) is the most common and aggressive form of brain cancer. Even with treatment, most people diagnosed with GBM survive less than 15 months. The goal of my research is to find ways to help these patients live better and longer lives. To achieve this goal, I will examine how LITT affects the immune system, our bodies’ natural defense system. I will look at how immune cells within the tumor and surrounding brain respond to LITT and track the response over time. I will then combine LITT with a new drug that also enhances the immune response to see if this results in a more effective treatment. I hope to show that by making specific changes to the immune system, a tumor-supportive environment can be converted to a tumor-hostile environment, improving anti-tumor effects. A better understanding of how LITT treatments and immune responses interact in inoperable GBM will help guide future treatments for this devastating disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506255
Name
Spence Jeremy
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting glioblastoma with laser thermal treatment and innate immune reprogramming.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Glioblastoma; Hypertheria; Hyperthermia; Immune; Laser; Litt; Murine; Thermal; Tme
Abstract
Combining laser heat with a new drug therapy for better patient outcomes in the fight against brain cancer. Laser Interstitial Thermal Therapy (LITT) is a type of treatment that uses a laser to heat up and destroy cancer cells. The laser device is thin, flexible, and needs only a small hole in the skull for access to the tumor. This minimizes the amount of damage caused by the procedure, while also allowing treatments in areas of the brain that are hard for a surgeon to safely access. With minimal disruption to the surrounding healthy brain tissue and a quick post-operative recovery, LITT is an attractive treatment option, especially for very sick or otherwise high-risk patients. Glioblastoma multiforme (GBM) is the most common and aggressive form of brain cancer. Even with treatment, most people diagnosed with GBM survive less than 15 months. The goal of my research is to find ways to help these patients live better and longer lives. To achieve this goal, I will examine how LITT affects the immune system, our bodies’ natural defense system. I will look at how immune cells within the tumor and surrounding brain respond to LITT and track the response over time. I will then combine LITT with a new drug that also enhances the immune response to see if this results in a more effective treatment. I hope to show that by making specific changes to the immune system, a tumor-supportive environment can be converted to a tumor-hostile environment, improving anti-tumor effects. A better understanding of how LITT treatments and immune responses interact in inoperable GBM will help guide future treatments for this devastating disease.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Spence, Jeremy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~